ANGIEX
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis. Angiex’s lead product is an antibody-drug conjugate therapy for cancer. Angiex was launched with IP from Beth Israel Deaconess Medical Center, is resident at LabCentral in Cambridge.
ANGIEX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.angiex.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
32.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Dieu` Dono, Co.
DIEU’ DONO CO. was founded by world-class biotech scientists and beauty experts and is a trusted name in Health and Beauty.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
QurAlis
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for ALS.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Thiel Capital
Thiel Capital investment in Series B - Angiex
Presight Capital
Presight Capital investment in Series B - Angiex
Presight Capital
Presight Capital investment in Venture Round - Angiex
Thiel Capital
Thiel Capital investment in Series A - Angiex
MassChallenge
MassChallenge investment in Non Equity Assistance - Angiex
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-22 | Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer |
Official Site Inspections
http://www.angiex.com Semrush global rank: 3.77 M Semrush visits lastest month: 3.58 K
- Host name: olympus-lon.cloudhosting.uk
- IP address: 185.199.220.69
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
